Das Ende des Alterns

David A. Sinclair has achieved one of the greatest breakthroughs in biology: he has not only slowed down aging in laboratory animals but reversed it. If the trials with humans at Harvard University are successful, the first anti-aging pill will soon hit the market. Our genome suffers damage over the decades. These damages to our DNA strands cause us to age and make us more susceptible to diseases. The epigenome – that pulsating structure in which our genome is wrapped – determines which of our genes become active and which do not. When genes are turned off, it harms the organism. David A. Sinclair is researching how to reactivate the right genes to heal the organism. Currently, American IT companies as well as the Chinese government are investing billions in research to make the epigenetic revolution a reality soon. This will lead to exciting possibilities, but also to profound moral and strategic dilemmas. Nominated for the Science Book of the Year in the Medicine & Biology category, awarded by the Austrian Federal Ministry of Education, Science and Research! “An elegant, thrilling book that deserves to be read attentively and thoroughly.” Siddhartha Mukherjee, cancer researcher and Pulitzer Prize winner. “Prepare to be blown away. In your hands, you hold the precious results of decades of work, conveyed by Dr. David A. Sinclair, the star in the study of aging and longevity.” Dave Asprey, founder and CEO of Bulletproof and author of the New York Times bestseller The Bulletproof Diet. “The geneticist who is making the reversal of aging a reality.” David Agus, TIME 100 Most Important People. “I have never read such a visionary book about aging. Enjoy this book!” Dean Ornish, MD, founder and president of Preventive Medicine.